How Does Gelagen Work?

The seller's own how-it-works panel describes a habit rather than a pathway: take daily, gummy formula, daily routine, follow the label.

1. Take daily. Two gummies with water.
2. Gummy formula. Selected vitamins.
3. Daily routine. Make it consistent.
4. Follow the label. Use as directed.

Four steps, and not one of them names a mechanism. The same artwork picks six of the thirteen nutrients out for the front of the panel, Vitamin A, Vitamin C, Vitamin D, Vitamin E, Biotin and Zinc, and leaves the other seven in the list below. It says nothing about what any of the six is doing.

That is less evasive than it first reads. A supplement is not permitted to describe a disease process, and a seller who writes a pathway into marketing copy has to be able to stand behind it. What the artwork offers instead is the routine, which is the only part of this a buyer controls. Everything below is the public record for these nutrients rather than the seller's account of the product.

The fourth step is worth taking literally. Follow the label means two gummies, chewed, with a full glass of water, about half an hour before a morning or afternoon meal, and it means the same two gummies on the days nothing seems to be happening. A panel describes what one serving supplies. It has nothing to say about a serving that was skipped, and the seller's own four steps are, read plainly, an instruction about consistency rather than about chemistry.

Vitamin C is required by the enzymes that stabilise collagen as it forms, which is a statement about the body rather than about any product.

The public record puts it plainly: vitamin C is required for the biosynthesis of collagen, and a shortage impairs collagen synthesis and weakens connective tissue. Collagen is the protein that gives skin its structure, so the nutrient sits upstream of the thing the seller's claims are about. Being required for a process is not the same as speeding it up, and nothing in that record says more vitamin C than a body needs builds more collagen. Zinc is used in protein and DNA synthesis and in wound healing, which is the housekeeping every dividing tissue depends on, skin and the nail matrix included. The same record notes that zinc deficiency causes alopecia. The panel prints 2.7 mg, about a quarter of the adult Daily Value, so it is a contribution to that supply rather than the supply itself. Pantothenic acid's main job is making coenzyme A, which sits in the middle of fatty-acid metabolism. B6, B12 and folate are cofactors in amino-acid and one-carbon metabolism, and hair and nail are very largely protein. That is the honest register for the whole B group on this panel: raw material for processes the body already runs, at amounts near a day's worth rather than at pharmacological ones.

The shape of that argument matters more than any single nutrient in it. Every sentence above describes what a nutrient does in a body, and every one of them comes from a public nutrient reference rather than from a study of this gummy. A nutrient with a job to do is a reason a panel is worth reading. It is not evidence that a product changes anything in somebody who already has enough of it.

Correcting a biotin deficiency changes hair and nails. In people who are not deficient the published evidence is thin, and saying so is the point of a page like this one.

Both halves come from the same place. The NIH Office of Dietary Supplements records that signs of biotin deficiency include skin rashes, hair loss and brittle nails, so the link between this nutrient and these tissues is real. The same sheet, on supplementation, describes the brittle-nail evidence as “three small studies that did not include a placebo group” which “do not indicate the baseline biotin status of study participants”. In them nail thickness rose 25% in eight patients and 7% in fourteen, and the second of those results was not statistically significant.

A systematic review of biotin for hair loss found eighteen reported cases in the literature, and in every one the patient already had an underlying cause of poor hair or nail growth; its conclusion was a lack of sufficient evidence for supplementation in healthy individuals. A companion paper from the same year put the gap more bluntly: to that date there had been no clinical trial of biotin for alopecia of any kind, and no randomised trial of its effect on hair quality or quantity in humans.

So the claim this label can carry is narrow, and the claim buyers arrive with is wide. Deficiency is the setting in which biotin changes hair and nails, and deficiency is uncommon in people eating an ordinary diet. Somebody short of it has something to gain. Somebody who is not is adding to a supply that was already adequate, and no published trial describes what that does.

It helps to know what the deficiency actually looks like, because it is the setting every supported sentence above belongs to. At consumer reading level the signs are the same three: skin rashes, hair loss and brittle nails. The same page notes that there are no known toxic symptoms from biotin, which is the other half of why a figure like 5,000 mcg can be printed at all. Deficiency is uncommon, it is not something a label can diagnose, and a person who has it usually has a reason for it.

None of that makes 5,000 mcg wrong to print. It makes it a number to understand before buying rather than a reason to buy. The one practical consequence of taking biotin at supplement amounts is about laboratory work rather than about hair, and it has a section of its own on the safety page.

No trial has been published on the finished gummy, so nothing here describes what the product has been shown to do.

Three further gaps are worth naming together rather than one at a time. Nobody has measured how much of each nutrient a chewable delivers against a capsule carrying the same amount. Nobody has measured what this particular combination of thirteen does that its parts would not. And no figure on the panel can tell you whether you were short of any of them before the first gummy, which is the variable that decides the size of any change.

One survey of 176 skin, hair and nail supplements taken off the shelves of seven stores found that most lacked independent testing, that many printed outdated Daily Values and that most carried health-related marketing claims. That is one shelf survey rather than a general truth about the category, and it is a fair description of the aisle this jar sits in.

It is worth being concrete about what would close the gap, because the answer is not exotic. A trial of the finished gummy, against a placebo, in people whose biotin and zinc status had been measured before they started, running long enough for a nail to grow out and measuring the nail rather than asking about it. That study would settle the question for this product in a way no amount of reading a panel ever can.

What is left is a fair description of the offer. A printed panel, thirteen public references to read it against, thirty days in a jar and sixty days from the purchase in which to decide. That is more than most of this shelf hands a buyer, and it is less than proof.